When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common symptoms include dizziness, vertigo, tremor, nausea, insomnia, fatigue, mood dysregulation, anxiety, panic, irritability and agitation (Fava et al., 2015; Haddad and Anderson, 2007; Jha et al., 2018).”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Jha et al., 2018
In the citing paper
“Clonazepam [73-76] has a long elimination half-life, induced less frequently rebound anxiety than alprazolam [77].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [76]
In the citing paper
“Rather, characteristics of the individual may be more important; posited, among other potentially predisposing factors, are lengthy drug treatment, medication switches, abrupt discontinuation, inadequate tapering, prior difficulty in withdrawal or other adverse drug events and physiological vulnerability.20,23,30,41–43”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [23]
In the citing paper
“It is now suspected that antidepressant withdrawal syndrome is more common and severe than earlier presumed, affecting roughly 30–50% of those who attempt to stop their treatment.12,13,23,24”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [23]
In the citing paper
“When withdrawal symptoms emerge in the acute phase of antidepressant withdrawal, reinstatement of the drug to treat them is recommended throughout the scientific literature and in many new-generation antidepressant package inserts.11,13,23,28,44”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [23]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Self-citationRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Self-citationKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303
Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects
WISNIEWSKI, S. R., RUSH, A. J., BALASUBRAMANI, G. K., TRIVEDI, M. H., & NIERENBERG, A. A. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200603000-00002 · Cited by 288
Self-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T., Grannemann, B., Soyombo, A., Mayes, T. L., Rush, A. J., & Trivedi, M. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.023 · Cited by 206
Self-citationMontgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196
Zeier, Z., Carpenter, L. L., Kalin, N. H., Rodriguez, C. I., McDonald, W. M., Widge, A. S., & Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17111282 · Cited by 192
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R., & Tepner, R. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.363 · Cited by 181
Hunot, V. M., Horne, R., Leese, M. N., & Churchill, R. C. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0202 · Cited by 180
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Antidepressant discontinuation syndromes
Haddad, P. M., Anderson, I., & Rosenbaum, J. (2004) · Adverse Syndromes and Psychiatric Drugs · doi:10.1093/med/9780198527480.003.0010 · Cited by 160
(1997) · PubMed · Cited by 149
Neumaier, J., Root, D. C., & Hamblin, M. W. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00095-4 · Cited by 145
Senay, E. C., Adams, E. H., Geller, A., Inciardi, J. A., Muñoz, Á., Schnoll, S. H., WOODY, G. E., & Cicero, T. J. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00321-6 · Cited by 136
Extemporaneous drug formulations
Nahata, M. C., & Allen, L. V. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.11.020 · Cited by 129
The SSRI discontinuation syndrome
Haddad, P. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 126
Renoir, T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00045 · Cited by 107
Baldwin, D. S., Cooper, J. A., Huusom, A. K. T., & Hindmarch, I. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000194377.88330.1d · Cited by 100
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
Stahl, M. M. S., Lindquist, M., Pettersson, M., Edwards, I. R., Sanderson, J. H., Taylor, N. F. A., Fletcher, A. P., & Schou, J. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050357 · Cited by 97
Hypomania and mania after withdrawal of tricyclic antidepressants
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.87 · Cited by 95
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00002 · Cited by 87
Safety of Abrupt Discontinuation of Fluoxetine: A Randomized, Placebo-Controlled Study
Zajecka, J., Fawcett, J., Amsterdam, J., Quitkin, F., Reimherr, F., Rosenbaum, J., Michelson, D., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00003 · Cited by 85
Bogetto, F., Bellino, S., Revello, R. B., & Patria, L. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00006 · Cited by 80
Fava, G. A., Bernardi, M., Tomba, E., & Rafanelli, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007462 · Cited by 80
Yonkers, K. A., Kornstein, S. G., Gueorguieva, R., Merry, B., Van Steenburgh, K., & Altemus, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1472 · Cited by 78
EEG lateral asymmetries in psychiatric disorders
Serafetinides, E. A. (1984) · Biological Psychology · doi:10.1016/0301-0511(84)90040-1 · Cited by 78
Popa, D., Cerdan, J., Repérant, C., Guiard, B. P., Guilloux, J., David, D. J. P., & Gardier, A. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.037 · Cited by 77
Physical symptoms associated with paroxetine discontinuation
Barr, L. C., Goodman, W. K., & Price, L. H. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.289 · Cited by 71
Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression
Harvey, B. H., McEwen, B. S., & Stein, D. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00528-6 · Cited by 65
Henry, M. E., Moore, C. M., Kaufman, M. J., Michelson, D., Schmidt, M. E., Stoddard, E., Vuckevic, A. J., Berreira, P. J., Cohen, B. M., & Renshaw, P. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1506 · Cited by 61
Adverse events after the abrupt discontinuation of paroxetine
Dominguez, R. A., & Goodnick, P. J. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb02896.x · Cited by 57
Extrapyramidal symptoms upon discontinuation of fluoxetine
Stoukides, J., & Stoukides, C. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1263a · Cited by 56
Medication Withdrawal Symptoms in Obsessive-Compulsive Disorder Patients Treated with Paroxetine
Keuthen, N. J., Cyr, P., Ricciardi, J. A., Minichiello, W. E., Buttolph, M. L., & Jenike, M. A. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199406000-00010 · Cited by 53
Jha, M. K., Minhajuddin, A., Greer, T. L., Carmody, T., Rush, A. J., & Trivedi, M. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16020176 · Cited by 53
Self-citationShock-like sensations after discontinuation of selective serotonin reuptake inhibitors
Frost, L., & Lal, S. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.810a · Cited by 49
FINISH: Remembering the Discontinuation Syndrome
Berber, M. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0509b · Cited by 47
Withdrawal Syndromes After Paroxetine and Sertraline Discontinuation
Fava, G. A., & Grandi, S. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00012 · Cited by 46
Severe psychiatric symptoms associated with paroxetine withdrawal
Bloch, M., Stager, S., Braun, A., & Rubinow, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92691-7 · Cited by 45
Discontinuation reactions following sertraline
Leiter, F. L., Nierenberg, A. A., Sanders, K. M., & Stern, T. A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00311-8 · Cited by 40
Bosker, F. J., Tanke, M. A. C., Jongsma, M. E., Cremers, T. I. F. H., Jagtman, E., Pietersen, C. Y., van der Hart, M. G. C., Gladkevich, A. V., Kema, I. P., Westerink, B. H. C., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.001 · Cited by 40
A possible paroxetine withdrawal syndrome
Phillips, S. D. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.645b · Cited by 39
Withdrawal reaction after sertraline discontinuation
Louie, A. K., Lannon, R. A., & Ajari, L. J. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.450b · Cited by 38
Physical symptoms associated with paroxetine withdrawal
DeBattista, C., & Schatzberg, A. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1235b · Cited by 37
Jha, M. K., Minhajuddin, A., South, C. C., Rush, A. J., & Trivedi, M. H. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx097 · Cited by 34
Self-citationParoxetine withdrawal syndrome
Pyke, R. E. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.149b · Cited by 31
Shock‐Like Sensations During Venlafaxine Withdrawal
Reeves, R. R., Mack, J. E., & Beddingfield, J. J. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.678.32198 · Cited by 30
Delirium following abrupt discontinuation of fluoxetine
Blum, D., Maldonado, J., Meyer, E., & Lansberg, M. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.08.016 · Cited by 28
Montgomery, S. A., Fava, M., Padmanabhan, S. K., J. Guico-Pabia, C., & Tourian, K. A. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832fbb5a · Cited by 27
Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change
Papakostas, G. I. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14077su1c.03 · Cited by 23
Einbinder, E. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1235a · Cited by 21
Antidepressant withdrawal syndrome
Young, A. H., Currie, A., & Ashton, C. H. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.3.288a · Cited by 16
Berardis, D. D., Serroni, N., Marini, S., Fornaro, M., Valchera, A., Martinotti, G., Giannantonio, M. D., & Kahn, D. A. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000450323.37038.a9 · Cited by 12
Kotzalidis, G., de Pisa, E., Patrizi, B., Savoja, V., Ruberto, G., & Girardi, P. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081562 · Cited by 7
Long-Term Duloxetine Withdrawal Syndrome and Management in a Depressed Patient
Hou, Y., & Lai, C. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12110265 · Cited by 7
Delirium Associated With Fluoxetine Discontinuation: A Case Report
Fan, K.-Y., & Liu, H. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000214 · Cited by 4
[Severe withdrawal symptoms with fever during paroxetine tapering off].
Peeters, F. P. M. L., & Zandbergen, J. (1999) · PubMed · Cited by 1
[Withdrawal syndrome after the use of serotonin reuptake inhibitors].
Fagan, M. (2000) · PubMed · Cited by 1
Research works printed but not linked: 8
- Targum SD, 2014, Innov Clin Neurosci, 11, 24
- Black DW, 1993, J Clin Psychiatry, 54, 146
- Berlin CS, 1996, J Clin Psychiatry, 57, 93
- Peeters FP, 1999, Ned Tijdschr Geneeskd, 143, 1429
- Bryois C, 1998, Praxis (Bern), 87, 345
- Fagan M, 2000, Tidsskr Nor Laegeforen, 120, 913
- Schatzberg AF, 1997, J Clin Psychiatry, 58, 5
- Warner CH, 2006, Am Fam Physician, 74, 449
Cited by
Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
Screening and Management of Depression in Patients With Cardiovascular Disease
Jha, M. K., Qamar, A., Vaduganathan, M., Charney, D. S., & Murrough, J. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.041 · Cited by 365
Self-citationAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Pharmacological Treatments for Patients with Treatment-Resistant Depression
Ruberto, V. L., Jha, M. K., & Murrough, J. W. (2020) · Pharmaceuticals · doi:10.3390/ph13060116 · Cited by 147
Self-citationJohnson, D., Thurairajasingam, S., Letchumanan, V., Chan, K., & Lee, L. (2021) · Nutrients · doi:10.3390/nu13051728 · Cited by 138
Metadata
- Authors
- Jha, M. K., Rush, A. J., & Trivedi, M. H.
- Affiliations
- National University of Singapore (SG)
- Venue
- American Journal of Psychiatry
- Published
- 2018-12-01
- Volume
- 175
- Issue
- 12
- Pages
- 1176-1184
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2902898025
- Cited by
- 73
- References
- 71
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 17
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- SSRI antidepressants, antidepressant discontinuation, medication management
- MeSH terms
- Adult, Depressive Disorder, Major, Major Depressive Disorder, Diagnosis, Differential, Female, Humans, Risk Factors, Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.